2. Academic Validation
  3. A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection

A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection

  • Cell Host Microbe. 2016 Aug 10;20(2):259-70. doi: 10.1016/j.chom.2016.07.004.
Nicholas J Barrows 1,  Rafael K Campos 1,  Steven T Powell 2,  K Reddisiva Prasanth 2,  Geraldine Schott-Lerner 2,  Ruben Soto-Acosta 2,  Gaddiel Galarza-Muñoz 2,  Erica L McGrath 3,  Rheanna Urrabaz-Garza 4,  Junling Gao 3,  Ping Wu 3,  Ramkumar Menon 4,  George Saade 4,  Ildefonso Fernandez-Salas 5,  Shannan L Rossi 6,  Nikos Vasilakis 6,  Andrew Routh 7,  Shelton S Bradrick 8,  Mariano A Garcia-Blanco 9
Affiliations

Affiliations

  • 1 Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, 301 University Blvd, Galveston, TX 77555, USA; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC 27710, USA.
  • 2 Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, 301 University Blvd, Galveston, TX 77555, USA.
  • 3 Department of Neuroscience and Cell Biology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA.
  • 4 Department of Obstetrics and Gynecology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA.
  • 5 Centro Regional de Investigación en Salud Publica INSP, 19 Poniente Esquina 4(a) Norte s/n, Colonia Centro, Tapachula, Chiapas 30700, C.P., Mexico.
  • 6 Department of Pathology, Center for Biodefense and Emerging Infectious Diseases, Center for Tropical Diseases, and Institute for Human Infections and Immunity, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA.
  • 7 Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, 301 University Blvd, Galveston, TX 77555, USA; Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA.
  • 8 Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, 301 University Blvd, Galveston, TX 77555, USA. Electronic address: ssbradri@utmb.edu.
  • 9 Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, 301 University Blvd, Galveston, TX 77555, USA; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Republic of Singapore. Electronic address: maragarc@utmb.edu.
PMID: 27476412 DOI: 10.1016/j.chom.2016.07.004
Abstract

Currently there are no approved vaccines or specific therapies to prevent or treat Zika virus (ZIKV) Infection. We interrogated a library of FDA-approved drugs for their ability to block Infection of human HuH-7 cells by a newly isolated ZIKV strain (ZIKV MEX_I_7). More than 20 out of 774 tested compounds decreased ZIKV Infection in our in vitro screening assay. Selected compounds were further validated for inhibition of ZIKV Infection in human cervical, placental, and neural stem cell lines, as well as primary human amnion cells. Established anti-flaviviral drugs (e.g., bortezomib and mycophenolic acid) and Others that had no previously known Antiviral activity (e.g., daptomycin) were identified as inhibitors of ZIKV Infection. Several drugs reduced ZIKV Infection across multiple cell types. This study identifies drugs that could be tested in clinical studies of ZIKV Infection and provides a resource of small molecules to study ZIKV pathogenesis.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z